Robert A Bermel1, Pablo Villoslada2. 1. From the Mellen Center for Multiple Sclerosis Treatment and Research (R.A.B.), Cleveland Clinic, OH; and the Center of Neuroimmunology, Institute Biomedical Research August Pi Sunyer (IDIBAPS) (P.V.), Hospital Clinic of Barcelona, Spain. bermelr@ccf.org. 2. From the Mellen Center for Multiple Sclerosis Treatment and Research (R.A.B.), Cleveland Clinic, OH; and the Center of Neuroimmunology, Institute Biomedical Research August Pi Sunyer (IDIBAPS) (P.V.), Hospital Clinic of Barcelona, Spain.
Authors: Kevin R Patel; Lenny E Ramsey; Nicholas V Metcalf; Gordon L Shulman; Maurizio Corbetta Journal: Neurology Date: 2016-06-15 Impact factor: 9.910